Results of first-line weekly paclitaxel (P) plus gemcitabine (G) in metastatic breast cancer (MBC): An AERO phase II trial

被引：0
|
作者：
Mousseau, M.
Serin, D.
Petit, T.
Priou, F.
Zelek, L.
机构：
[1] Hop Albert Michalon, Grenoble, France
[2] Inst St Catherine, Avignon, France
[3] Ctr Paul Strauss, Strasbourg, France
[4] CHD Oudairies, La Roche Sur Yon, France
[5] Hop Henri Mondor, Creteil, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1103
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Final results of first-line weekly paclitaxel plus gemcitabine in metastatic breast cancer (MBC): an AERO phase II trial
    Mousseau, M.
    Serin, D.
    Goubely-Brewer, Y.
    Petit, T.
    Priou, F.
    Zelek, L.
    BULLETIN DU CANCER, 2007, 94 (06) : 569 - 570
  • [2] Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial
    Karthaus, Meinolf
    Poddubnaya, Irina
    Churilova, L.
    Khazanov, R.
    Veremeychuk, T.
    Rumyantzeva, E.
    Garin, M.
    Brichkova, O.
    Heinrich, Bernhard
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [3] Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial.
    Karthaus, M.
    Poddubnaya, I.
    Churilova, L.
    Khasanov, R.
    Veremeychuk, T.
    Rumyantseva, E.
    Garin, M.
    Brichkova, O.
    Heinrich, B.
    Heinemann, V.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (27)
  • [4] Phase II trial biweekly paclitaxel (P), doxorubicin (D) and Gemcitabine (G) as first line chemotherapy for metastatic breast cancer (MBC): Preliminary results
    Lozano, A
    Sanchez-Rovira, P
    Medina, B
    Gonzalez, E
    Mohedano, N
    Jaen, A
    Porras, I
    Fernandez, M
    ANNALS OF ONCOLOGY, 1998, 9 : 18 - 18
  • [5] A randomized, phase II trial of weekly paclitaxel versus weekly paclitaxel plus carboplatin for first-line metastatic breast cancer.
    Robert, N
    Loesch, D
    Lindquist, D
    Ratnam, S
    Hyman, W
    Whittaker, T
    Logie, K
    Kruger, S
    Pippen, J
    Liu, L
    Goldstein, L
    Asmar, L
    BREAST CANCER RESEARCH AND TREATMENT, 2003, 82 : S129 - S129
  • [6] Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
    F Cappuzzo
    F Mazzoni
    A Gennari
    S Donati
    B Salvadori
    C Orlandini
    G L Cetto
    A Molino
    E Galligioni
    M Mansutti
    S Tumolo
    A Lucentini
    F Valduga
    S Bartolini
    L Crinò
    P F Conte
    British Journal of Cancer, 2004, 90 : 31 - 35
  • [7] Multicentric phase II trial of gemcitabine plus epirubicin plus paclitaxel as first-line chemotherapy in metastatic breast cancer
    Cappuzzo, F
    Mazzoni, F
    Gennari, A
    Donati, S
    Salvadori, B
    Orlandini, C
    Cetto, GL
    Molino, A
    Galligioni, E
    Mansutti, M
    Tumolo, S
    Lucentini, A
    Valduga, F
    Bartolini, S
    Crinò, L
    Conte, PF
    BRITISH JOURNAL OF CANCER, 2004, 90 (01) : 31 - 35
  • [8] A phase II study of paclitaxel and bevacizumab ± gemcitabine as first-line treatment for metastatic breast cancer (MBC): Interim safety results
    Brufsky, A. M.
    Hoelzer, K. L.
    Keaton, M. R.
    Beck, J. T.
    Krill-Jackson, E.
    Wang, Y.
    Hu, S.
    Vaughn, L. G.
    Shonukan, O. O.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [9] Gemcitabine (G) plus cisplatin (C) is a highly active regimen in first-line treatment of metastatic breast cancer (MBC): Results of a multicenter phase II trial
    Fuentes, H
    Calderillo, G
    Alexander, F
    Ramirez, M
    Avila, E
    Perez, L
    Aguirre, C
    EUROPEAN JOURNAL OF CANCER, 2002, 38 : S72 - S72
  • [10] Phase II trial of capecitabine and weekly paclitaxel as first-line therapy for metastatic breast cancer
    Blum, Joanne L.
    Dees, E. Claire
    Chacko, Aparna
    Doane, Lisa
    Ethirajan, Sukumar
    Hopkins, Judith
    McMahon, Richard
    Merten, Suzan
    Negron, Angel
    Neubauer, Marcus
    Ilegbodu, Des
    Boehm, Kristi A.
    Asmar, Lina
    O'Shaughnessy, Joyce A.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (27) : 4384 - 4390
12345